Session 2: Chemical Biology of Natural Products
Monday, January 12, 2015: 1:30 PM-4:55 PM
California Ballroom AB
Conveners:
William Fenical - Scripps Institution of Oceanography, La Jolla, CA and Jong-Seog Ahn - Korea Research Institute of Bioscience and Biotechnology, Cheongju,
What is the structural diversity we could generate and which modifications make sense from a therapeutic perspective; (chemical) modification; targeting; delivery.


1:30 PM
S8
Biosynthesis study of reveromycin: Aiming at a therapeutic agent to osteoclast related diseases
Hiroyuki Osada1, Makoto Kawatani2 and Shunji Takahashi1, (1)RIKEN Center for Sustainable Resource Science, Wako-shi, Saitama, (2)Antibiotics Laboratory, RIKEN
1:55 PM
S9
Posttranslational modifications in natural product biosynthesis
Prof. Wilfred van der Donk, Chemistry, Howard Hughes Medical Institute and the University of Illinois at Urbana-Champaign, Urbana, IL
2:20 PM
S10
Decoding and reprogramming complex biosynthetic pathways in microbes
Christian Hertweck, Leibniz Institute for Natural Product Research and Infection Biology (HKI), Jena
2:45 PM
S11
New compounds via activation of secondary metabolite biosynthesis gene clusters in terrestrial and marine Streptomyces
Sergey Zotchev1, Olga N. Sekurova1, Martin Jasyk2, Fernando Reyes3, Christian Rückert4, Jörn Kalinowski5, Kristin Degnes6, Håvard Sletta6 and Roderich Süssmuth2, (1)Department of Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway, (2)Institut für Chemie, Technische Universität Berlin, Berlin, Germany, (3)Fundación MEDINA, Granada, Spain, (4)Center for Biotechnology, University of Bielefeld, Bielfeld, Germany, (5)Center for Biotechnology, University of Bielefeld, Bielefeld, Germany, (6)Department of Biotechnology, SINTEF Materials and Chemistry, Trondheim, Norway
3:10 PM
Break
4:05 PM
S13
New target identification of angiogenesis from phenotypic screening of natural products
Ho Jeong Kwon, Dept. of Biotechnology, Yonsei University, Seoul
4:30 PM
S14
Inhibition of eukaryotic transcription by a natural product from Thunder God vine
Jun Liu, Departments of Pharmacology and Oncology, Johns Hopkins School of Medicine, Baltimore, MD
See more of: Invited Papers